Comparative bioinformatic analysis of the conserved domains, amino acid residues, and binding grooves of tumor necrosis factor

Medicinski Glasnik

Volumn 11, Issue 1, 2014, Pages 1-6

  Chakraborty, Chiranjib ^a   Agoramoorthy, Govindasamy ^b  

^a GALGOTIAS UNIVERSITY   (India)

^b TAJEN UNIVERSITY   (Taiwan)

Author keywords

Adipokine; Computational biology; Cytokine; Low cost drug; Molecular inhibitor

Indexed keywords

AMINO ACID; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOINFORMATICS; COMPUTER PROGRAM; GENE EXPRESSION; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN DOMAIN; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; BINDING SITE; BIOLOGY; COMPARATIVE STUDY; PROTEIN TERTIARY STRUCTURE;

AMINO ACIDS; BINDING SITES; COMPUTATIONAL BIOLOGY; LYMPHOTOXIN-ALPHA; PROTEIN STRUCTURE, TERTIARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893208058     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104:487-501.
2. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Nat Acad Sci USA 1975; 72:3666-70.
3. Wiemann B, Starnes CO. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Ther 1994; 64:529-64.
4. Kawakami M, Cerami A. Studies of endotoxin-induced decrease in lipoprotein lipase activity. J Exp Med 1981; 154:631-9.
5. Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985; 161:984-95.
6. Tracey KJ, Cerami A. Metabolic responses to cachectin/ TNF. A brief review. Immunol. Ann NY Acad Sci 1990; 587:325-31.
7. Fisher CJ, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E. Treatment of septic shock with the tumour necrosis factor receptor Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996; 334:1697-02.
8. Ousman SS, David S. MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 2001; 21:4649-56.
9. Scott KA, Arnott CH, Robinson SC, Moore RJ, Thompson RG, Marshall JF, Balkwill FR. TNF-α regulates epithelial expression of MMP-9 and integrin αvβ6 during tumour promotion. A role for TNF-α in keratinocyte migration? Oncogene 2004; 23:6954-66.
10. Ferreira SH, Lorenzetti BB, Cunha FQ, Poole S. Bradykinin release of TNF-alpha plays key role in the development of inflammatory hyperalgesia. Agents Actions 1993; 38:C7-C9.
11. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996; 4:387-96.
12. Palanki Ms, Erdman PE, Gayo-Fung LM, Shevlin GI, Sullivan RW, Goldman ME, Ransone LJ, Bennett BL, Manning AM, Suto MJ. Inhibitors of NF-kappaB and AP-1 gene expression:SAR studies on the pyrimidine portion of N-(3,5-bis (trifluoromethyl) phenyl) (2-chloro-4-(trifluoromethyl) pyrimidin-5-yl) carboxamide; NF-kappa B; Pyrimidines; Transcription Factor AP-1. J Med Chem 2000; 43:3995-04.
13. Sudhakar C, Nagabhushana A, Jain N, Swarup G. NF-κB Mediates tumor necrosis factor α-induced expression of optineurin, a negative regulator of NF-κB. PLoS One 2009; 4:e5114.
14. Black RA, Bird TA, Mohler KM. TNF-α synthesis or activity. Ann Rep Medic Chem 1997; 32:241-50.
15. Goetza FW, Planasb JV, MacKenziec, S. Tumor necrosis factors. Dev Comp Immunol 2004; 28:487-97.
16. Balzar S, Chu HW, Strand M, Wenzel S. Relationship of small airway chymase-positive mast cells and lung function in severe asthma. Am J Respir Crit Care Med 2005; 171:431-39.
17. Taylor PC. Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases. Curr Opin Pharmacol 2010; 10:308-15.
18. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet 2001; 358:903-911.
19. Eck MJ, Sprang SR. The structure of tumor necrosis factoralpha at 2.6 A resolution. Implications for receptor binding. J Biol Chem 1989; 264:17595-05.
20. Jones EY, Stuart DI, Walker NP. Structure of tumour necrosis factor. Nature 1989; 338:225-28.
21. He MM, Smith AS, Oslob JD, Flanagan WM, Braisted AC, Whitty A, Cancilla MT, Wang J, Lugovskoy AA, Yoburn JC, Fung AD, Farrington G, Eldredge JK, Day ES, Cruz LA, Cachero TG, Miller SK, Friedman JE, Choong IC, Cunningham BC. Small molecule inhibition of TNF-a. Science 2005; 310:1022.
22. Baeyens KJ, De Bondt HL, Raeymaekers A, Fiers W, De Ranter CJ. The structure of mouse tumour-necrosis factor at 1.4 A resolution: towards modulation of its selectivity and trimerization. Acta Crystallogr D Biol Crystallogr 1999; 55:772-78.
23. Sharma OP. Tumor necrosis factor polymorphism in sarcoidosis. Chest 2001; 119:678-679
24. Parham P. T cell-mediated immunity. The immune system, 2nd ed. New York: Garland Science Publishing 2005; 145-78.
25. Kuntz ID. Structure-based strategies for drug design and discovery. Science 1992; 257:1078-82.
26. Scapin G. Structural biology in drug design: selective protein kinase inhibitors. Drug Discov Today 2002; 7:601-11.
27. Wheeler DL, Barrett t, Benson DA, Bryant SH, Canese K, Chetvernin V, Church DM, DiCuccio M, Edgar R, Federhen S, Geer LY, Kapustin Y, Khovayko O, Landsman D, Lipman DJ, Madden TL, Maglott DR, Ostell J, Miller V, Pruitt KD, Schuler GD, Sequeira E, Sherry ST, Sirotkin K, Souvorov A, Starchenko G, Tatusov RL, Tatusova TA, Wagner L, Yaschenko E. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2007; 35:5-12.
28. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 2003; 31:3497-3500.
29. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 2009; 25:1189-91.
30. Edgar RC. MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004; 32:1792-97.
31. Herráez A. Biomolecules in the computer: Jmol to the rescue. Biochem. Mol Biol Edu 2006; 34:255-21.
32. Hanson RM. Jmol-a paradigm shift in crystallographic visualization. J Appl Crystal 2010; 43:1250-60.
33. Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N. ConSurf 2010; Calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res 2010; 38:529
34. Glaser F, Pupko T, Paz I, Bell RE, Bechor-Shental D, Martz E, Ben-Tal N. ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 2003; 19:163-64.
35. DeLano WL. The PyMOL Molecular Graphics System. 2002. http://www.pymol.org (15 June 2012).
36. Marchler-Bauer A, Anderson JB, Cherukuri PF, DeWeese-Scott C, Geer LY, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Liebert CA, Liu C, Lu F, Marchler GH, Mullokandov M, Shoemaker BA, Simonyan V, Song JS, Thiessen PA, Yamashita RA, Yin JJ, Zhang D, Bryant SH. CDD: a conserved domain database for protein classification. Nucleic Acids Res 2005; 33:192-96.
37. Lesk, AM. Introduction to Protein Science: Architecture, Function, and Genomics. Oxford: Oxford university press, 2010.
38. Tanaka N, Tani Y, Tada T, Lee YF, Kanaori K, Kunugi S. The Roles of conserved amino acids on substrate binding and conformational integrity of Clpb N-terminal domain. Biochemistry 2006; 45:8556-61.
39. Chakraborty C, Agoramoorthy G, Hsu MJ. Exploring the evolutionary relationship of insulin receptor substrate family using computational biology. PLoS One 2011; 6:e16580.
40. Boguski MS, Hardison RC, Schwartz S, Miller W. Analysis of conserved domains and sequence motifs in cellular regulatory proteins and locus control regions using new software tools for multiple alignment and visualization. New Biol 1992; 4:247-260.